AGADA uses a one-step RT-PCR with gene-specific primers to detect the skipped versus non-skipped dystrophin gene.  The final data is provided as % skipped, % non-skipped, % molarity of the skipped and % molarity of the non-skipped dystrophin gene. The assay can be tailored to meet the sponsor’s need and validated prior to the testing clinical samples.